NEW YORK (GenomeWeb News) – The Center for Translational Molecular Medicine, a Dutch public-private partnership founded a year ago, said that it has awarded a total of €100 million ($128 million) to eight new research projects targeting cancer, cardiovascular, neurodegenerative, and infectious diseases.
The new round of funding brings the total amount of money awarded to research projects by CTMM since its founding to nearly €250 million.
The eight new projects include 13 university medical centers and research institutes, 29 expert small- and medium-sized enterprises, and 15 "major" industrial players, said CTMM. Fifty percent of the total funding was provided by the Dutch government, with the other 50 percent coming from industry and academia.
CTMM did not provide details regarding the eight projects, but it said that included among them are projects to develop new technology platforms that could be applied across a broad spectrum of diseases.
CTTM also said that it would follow the advice of its International Scientific Advisory Committee and "continue to provide selective investments in centralized infrastructures for CTMM projects to address the rapidly increasing demand for advanced genomics, proteomics, metabolomics, and bioinformatics."